Dr Dana Rizk is Tenured Professor of Medicine in the Division of Nephrology and Associate Dean for Clinical Trials at the University of Alabama at Birmingham (UAB) Heersink School of Medicine. Her clinical and research interests revolve around rare glomerular diseases and, in particular IgA Nephropathy (IgAN). She has served as the site principal investigator on many clinical trials and is part of several multi-disciplinary translational research projects focused on the role of biomarkers in the diagnosis and prognosis of IgAN. Her research efforts have resulted in more than 80 peer-reviewed publications in prestigious medical journals including the New England Journal of Medicine.